Acute Coronary Syndromes
114
17
20
59
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Research Maturity
59 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.5%
4 terminated out of 114 trials
93.7%
+7.1% vs benchmark
29%
33 trials in Phase 3/4
15%
9 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (114)
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients
Coronary Laser Atherectomy Registry From an International Taskforce
ALIGN-ACS Pilot Study
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Prospective Cohort of Acute Cardiology Referrals in an Ambulatory Day-Hospital Setting
Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort
Oregano and Basil Leaves and Coronary Artery Disease
Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease
Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
AI-Enhanced Single-Lead ECG Screening for Coronary Stenosis
Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes
Point-of-Care Troponin Testing in the Emergency Department
A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US
A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices
triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE
Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies